This article examines why healthcare innovation has entered this new phase, how institutional investment strategies are evolving, and why multidisciplinary innovation platforms are becoming more important than conventional investment funds in shaping the future of HealthTech.

The establishment of the Dubai Longevity Authority marks a significant evolution in UAE healthcare governance. More than a new regulatory body, it signals a strategic shift in how governments are approaching longevity, life sciences and the transition from lifespan to healthspan as the central objective of modern healthcare systems.